Max Robotics — Global Service Robot Directory + US Certification

About

Daniel Sidhom is a urologic surgeon and researcher whose work spans the frontiers of robotic surgery, surgical education, and immuno-oncology. His research is defined by a commitment to improving patient outcomes through minimally invasive techniques and rigorous skills assessment. In a landmark study on robotic pyelolithotomy, Sidhom demonstrated the safety and efficacy of this advanced approach for complex kidney stones, reporting excellent outcomes and a low complication rate—work that has garnered 17 citations and helped establish robotic surgery as a viable option in endourology. He also made foundational contributions to surgical training, co-authoring a highly cited 2012 study that tracked technical skill acquisition among urology residents over four years. This work, with 14 citations, provided objective, longitudinal data on the learning curves for open, laparoscopic, and robotic skills, challenging anecdotal assessment methods and influencing how residency programs evaluate competence. Most recently, Sidhom has ventured into the cutting-edge arena of adjuvant immunotherapy for high-risk upper tract urothelial carcinoma. As part of the ROBUUST 2.0 Collaborative Group, his 2025 study is already shaping the conversation around personalized oncologic care. Through this blend of clinical innovation, educational rigor, and translational research, Sidhom continues to advance the field of urology.